Northern Trust Corp Vaxcyte, Inc. Transaction History

Northern Trust Corp

$572 Billion
Q1 2024

A detailed history of Northern Trust Corp transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 968,757 shares of PCVX stock, worth $73.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

968,757

Previous 884,268 9.55%

Holding current value

$73.2 Million

Previous $55.5 Million 19.17%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$59.79 - $81.05 $5.05 Million - $6.85 Million	84,489 Added 9.55%	968,757 $66.2 Million
Q4 2023 Feb 13, 2024	SELL	$45.35 - $63.41 $560,843 - $784,191	-12,367 Reduced 1.38%	884,268 $55.5 Million
Q3 2023 Nov 13, 2023	BUY	$46.0 - $53.1 $1.64 Million - $1.9 Million	35,694 Added 4.15%	896,635 $45.7 Million
Q2 2023 Aug 11, 2023	BUY	$34.66 - $54.07 $6.68 Million - $10.4 Million	192,639 Added 28.83%	860,941 $43 Million
Q1 2023 May 15, 2023	BUY	$36.27 - $47.2 $325,378 - $423,431	8,971 Added 1.36%	668,302 $25 Million

Q4 2022 Feb 13, 2023	BUY	$20.58 - $47.95 $3.61 Million - $8.41 Million	175,439 Added 36.26%	659,331 $31.6 Million
Q3 2022 Nov 14, 2022	BUY	$21.69 - $28.53 $424,147 - $557,904	19,555 Added 4.21%	483,892 $11.6 Million
Q2 2022 Aug 12, 2022	BUY	$17.68 - $26.58 $1.45 Million - $2.19 Million	82,212 Added 21.51%	464,337 $10.1 Million
Q1 2022 May 13, 2022	BUY	$17.46 - $26.36 $186,175 - $281,076	10,663 Added 2.87%	382,125 $9.23 Million
Q4 2021 Feb 08, 2022	SELL	$19.32 - $26.45 $70,421 - $96,410	-3,645 Reduced 0.97%	371,462 $8.84 Million
Q3 2021 Nov 15, 2021	BUY	$20.26 - $26.97 $191,558 - $255,001	9,455 Added 2.59%	375,107 $9.52 Million
Q2 2021 Aug 13, 2021	BUY	$16.45 - $24.06 $1.23 Million - $1.8 Million	74,694 Added 25.67%	365,652 $8.23 Million
Q1 2021 May 12, 2021	BUY	$18.66 - $29.16 $1.27 Million - $1.98 Million	67,838 Added 30.4%	290,958 $5.75 Million
Q4 2020 Feb 11, 2021	BUY	$26.57 - $51.74 $228,316 - $444,601	8,593 Added 4.01%	223,120 $5.93 Million
Q3 2020 Nov 16, 2020	BUY	$26.5 - $55.4 $5.68 Million - $11.9 Million	214,527 New	214,527 $10.6 Million

Others Institutions Holding PCVX

# of Institutions

269

Shares Held

97.1M

Call Options Held

202K

Put Options Held

147K

View Full List

About Vaxcyte, Inc.

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $4.48B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

More about PCVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Vaxcyte, Inc. Transaction History